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Purpose:  Amyloidotic cardiomyopathy (AC) can mimic other diseases with left ventricular (LV) hypertrophy, including hypertrophic cardiomyopathy 
(HCM) and hypertensive heart disease (HHD). Low QRS voltage on ECG provides valuable clues for the non-invasive suspicion of AC. However its 
sensitivity is limited and its diagnostic accuracy has been mainly tested in primary (AL) amyloidosis. We assessed the diagnostic performance of 
low QRS voltage and of two other indexes combining ECG and echocardiographic information for the diagnosis of AC in a context of patients with LV 
“hypertrophy” due to either different etiologies of amyloidosis or HCM or HHD.
Methods: We studied 570 patients: 262 AC (161 AL; 101 transthyretin-related [71 mutant (ATTR), 30 wild-type (SSA)]); 207 HCM; 101 HHD. Three 
indexes were compared: 1) low QRS voltage (QRS amplitude ≤0.5 mV in limb leads); 2) Sokolow index (sum of S wave in lead V1 plus R wave in lead 
V5 or V6) divided by the cross-sectional area of LV wall (according to the formula of Carroll JD, 1982), 3) total QRS score (sum of QRS voltages in 
all the ECG leads) divided by indexed LV mass (g/m2). The different criteria were tested in the following clinical scenario: all the AC (AL+ATTR+SSA) 
vs HCM+HHD; all the AC vs HCM; AL vs HCM+HHD; AL vs HCM. ROC curves were constructed to identify the best cut off values for the two criteria 
expressed by continuous variables.
Results: Low QRS voltage was present in 48% of AC patients (62% in AL, 24% in ATTR, 27% in SSA). For the identification of AC the low QRS voltage 
showed high specificity (>90%%) but low sensitivity, especially when considering all aetiologies of amyloidosis (sensitivity=48%). Indexes combining 
ECG/echocardiographic findings both showed a higher overall diagnostic performance, where total QRS score divided by LV indexed mass showed 
the best diagnostic performance (sensitivity=81-87%; specificity=79-82%) in all clinical scenarios.
Conclusions: In patients with unexplained LV hypertrophy, AC can be accurately, non invasively identified by combining ECG/ECHO findings, where 
total QRS score divided by LV indexed mass provides the best diagnostic performance, particularly when AC is not only related to AL etiology.
